Innovating antibodies, improving lives

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

 

financial results 260x173 homepageGenmab's First Half 2019 Financial Results

Genmab published its First Half 2019 financial results on August 14, and held an investor conference call to discuss the results.  Click here to download the report, here to listen to the webcast replay, here to download an MP3 of the webcast and here to download the webcast slides. 

 

join our team_260x173Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members. Click here to visit Genmab's page on LinkedIn.    

 

 

Genmab 20 Years LogoCelebrating 20 Years

Genmab celebrates its 20th anniversary this year. We asked employees and external stakeholders for their perspectives on Genmab. Click here to watch the video and find out what they said.